Depression in children with thalassemia major: prevalence and contributing factors
Journal Title: Paediatrica Indonesiana - Year 2018, Vol 58, Issue 6
Abstract
Background Thalassemia major is a chronic disease requiring lifetime treatment. A recent study showed that 11-62% of thalassemia patients developed depression, which is associated with high morbidity and mortality. Understanding the extent of the problem related to depression and its contributing factors is important for early management. Objective To determine the prevalence and contributing factors for depression in children with thalassemia major. Methods This cross-sectional observational analytic study included thalassemia major patients aged 7 to <18 years in the Department of Child Health, Dr. Moh. Hoesin General Hospital (RSMH) in Palembang from June to July 2018 and had received blood transfusions at least 3 times. Subjects completed the Children’s Depression Inventory (CDI) questionnaire. Depression was defined as a total score > 13. Data were analyzed using SPSS for Windows ver. 22.0. Results There were 64 patients included in this study, with mean age 12 (SD 3) years and 82.8% female. Most subjects came from families with low socio-economic status and low parental education. Deferiprone was the most commonly used type of iron-chelating agent. Depression was detected in 34.4% of respondents. Multivariate analysis revealed that factors affecting depression in children with thalassemia major were low maternal education (OR 4.014; 95%CI 1.066 to 15.112) and use of deferasirox (OR 4.129; 95%CI 1.168 to 14.601). Conclusion Prevalence of depression in children with thalassemia major is 34.4%. Low maternal education and deferasirox use as an iron-chelating agent are associated with depression in children with thalassemia major.
Authors and Affiliations
Venty Venty, Rismarini Rismarini, Dian Puspitasari, Yudianita Kesuma, Raden Indra
Keywords
Related Articles
- EP ID EP508848
- DOI 10.14238/pi58.6.2018.263-8
- Views 62
- Downloads 0
Behavioral problems in children with epilepsy
Background Epilepsy is a neurological disorder that most oftenaffects children. Most cases of epilepsy are found in developingcountries. Children with epilepsy are at risk of behavioral disordersthat can affect their qua...
Hematological scoring system as an early diagnostic tool for neonatal sepsis
Background Sepsis was the leading cause of death in babies by 30%-50% in developing countries. Early diagnosis of neonatal sepsis is still a difficult problem because of clinical features are not specific. Blood culture...
Efficacy of aminophylline vs. caffeine for preventing apnea of prematurity
Background Apnea of prematurity (AOP) usually occursin neonates with a gestational age < 34 weeks. The WorldHealth Organization has recommended the administration ofcaffeine or aminophylline to prevent AOP, but the ef...
Efficacy of sputum induction from lower respiratory tract in children
Background Although sputum is a good specimen for variousexaminations, such as cytology and microbiological culture,sputum induction (SI) is not a routine procedure in children.Objective To identify the efficacy of SI to...
Liver function in children with human immunodeficiency virus infection before and after 6 months of highly active antiretroviral therapy
Background Highly active antiretroviral therapy (HAART) has resulted in dramatic decreases in morbidity and improved survival rate in human immunodeficiency virus (HIV)-infected patients. Although the risk of morbidity h...